SwitzerReport

Independent. Trusted. Proven.

Reports

Browse current and previous editions of Switzer Report

Monday Edition, 6 May 2024
Maureen Jordan

HOT stock: Amcor (AMC)

Maureen Jordan · May 6, 2024

For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains why he considers Amcor (AMC) an an ADD to an investor’s portfolio.

Investing Premium
James Dunn

3 speculative stocks on Australia’s critical minerals list

James Dunn · May 6, 2024

Australia has large reserves of many critical minerals. Last year, high-purity alumina (HPA) was officially added to our critical minerals list. These minerals are used in high-technology items with rising consumer demand, particularly in China, North America, and Europe. Here are three companies in the HPA market I think are worth a closer look – though this kind of investment must be considered speculative.

Investing Premium
Switzer on Saturday, 4 May 2024
Peter Switzer

It’s all about jobs!

Peter Switzer · May 4, 2024

While I can’t use the f-word, I’d like to after the US at long last got a downbeat jobs report, to which I say: “At long, freaking last!” Yep, that’s got it out of me...

Switzer on Saturday Premium
Thursday Edition, 2 May 2024
Paul Rickard

Questions of the Week

Paul Rickard · May 2, 2024

How can I play the copper boom? What’s happening with the takeover of Altium, it seems to have gone into an information blackout? Macquarie Telecom is raising capital, but retail shareholders aren’t being included. Should I be outraged? Have these three stocks bottomed?

Q&A Premium
Monday Edition, 29 April 2024
Paul Rickard

Changes to super: how they’ll impact you!

Paul Rickard · April 29, 2024

In this article, I’ll look at the three changes for this year, and what we know about the new super tax on balances over $3 million (and if you’re impacted, what you may want to do).

Investing Premium
Maureen Jordan

HOT stock: Resmed (RMD)

Maureen Jordan · April 29, 2024

For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains why Morgans views Resmed (RMD) as an ADD to an investor’s portfolio.

Investing Premium
James Dunn

Two more tailwind stocks

James Dunn · April 29, 2024

Here are two more stocks with substantial tailwinds behind them. Both companies are at the heart of transforming how their respective industries do things, and their growth prospects look very attractive.

Investing Premium
1 62 63 64 65 66 109

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.